Concord Biotech Management
Management criteria checks 3/4
Concord Biotech's CEO is Ankur Vaid, appointed in Jun 2021, has a tenure of 2.92 years. total yearly compensation is ₹31.86M, comprised of 90.6% salary and 9.4% bonuses, including company stock and options. directly owns 1.08% of the company’s shares, worth ₹1.88B. The average tenure of the management team and the board of directors is 2.2 years and 7.3 years respectively.
Key information
Ankur Vaid
Chief executive officer
₹31.9m
Total compensation
| CEO salary percentage | 90.6% |
| CEO tenure | 2.9yrs |
| CEO ownership | 1.1% |
| Management average tenure | 2.2yrs |
| Board average tenure | 7.3yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹3b |
| Sep 30 2023 | n/a | n/a | ₹3b |
| Jun 30 2023 | n/a | n/a | ₹2b |
| Mar 31 2023 | ₹32m | ₹29m | ₹2b |
| Mar 31 2022 | ₹20m | ₹16m | ₹2b |
| Mar 31 2021 | ₹12m | n/a | ₹2b |
| Mar 31 2020 | ₹8m | n/a | ₹2b |
Compensation vs Market: Ankur's total compensation ($USD382.26K) is about average for companies of similar size in the Indian market ($USD431.82K).
Compensation vs Earnings: Ankur's compensation has increased by more than 20% in the past year.
CEO
Ankur Vaid (41 yo)
2.9yrs
Tenure
₹31,863,000
Compensation
Mr. Ankur Vaid serves as Joint Managing Director and the Chief Executive Officer at Concord Biotech Limited since June 1, 2021 and serves as its Director since December 4, 2009. He has been associated with...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 24yrs | ₹204.63m | 38.46% ₹ 66.7b | |
| Joint MD | 2.9yrs | ₹31.86m | 1.08% ₹ 1.9b | |
| Chief Financial Officer | 2.2yrs | ₹5.47m | no data | |
| Company Secretary | no data | ₹3.89m | 0.021% ₹ 36.5m | |
| VP of Sales & Marketing and Head of Limbasi Plant-3 | no data | no data | 0.011% ₹ 18.2m | |
| VP of Formulation Division & Head of Valthera Unit-2 | 2.2yrs | no data | no data |
2.2yrs
Average Tenure
Experienced Management: CONCORDBIO's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 24yrs | ₹204.63m | 38.46% ₹ 66.7b | |
| Joint MD | 14.4yrs | ₹31.86m | 1.08% ₹ 1.9b | |
| Independent Director | 1.9yrs | ₹200.00k | no data | |
| Non-Executive Nominee Director | 15.9yrs | ₹888.00k | 0.12% ₹ 216.4m | |
| Independent Director | 7.3yrs | ₹220.00k | no data | |
| Independent Director | 2yrs | ₹200.00k | no data | |
| Non-Executive Director | 20.4yrs | ₹1.35m | 0.11% ₹ 182.5m | |
| Independent Director | 7.3yrs | ₹170.00k | no data | |
| Independent Director | 1.9yrs | ₹150.00k | no data |
7.3yrs
Average Tenure
63yo
Average Age
Experienced Board: CONCORDBIO's board of directors are considered experienced (7.3 years average tenure).